CYLD encodes a tumor suppressor that is mutated in familial cylindromatosis. Despite biochemical and cell culture studies, the physiological functions of CYLD in animal development and tumorigenesis remain poorly understood. To address these questions, we generated Drosophila CYLD (dCYLD) mutant and transgenic flies expressing wild-type and mutant dCYLD proteins. Here we show that dCYLD is essential for JNK-dependent oxidative stress resistance and normal lifespan. Furthermore, dCYLD regulates TNF-induced JNK activation and cell death through dTRAF2, which acts downstream of the TNF receptor Wengen and upstream of the JNKK kinase dTAK1. We show that dCYLD encodes a deubiquitinating enzyme that deubiquitinates dTRAF2 and prevents dTRAF2 from ubiquitin-mediated proteolytic degradation. These data provide a molecular mechanism for the tumor suppressor function of this evolutionary conserved molecule by indicating that dCYLD plays a critical role in modulating TNF-JNK-mediated cell death.
INTRODUCTION
Mutations in the tumor suppressor CYLD have been associated with familial cylindromatosis (Brooke-Spiegler syndrome), an autosomal dominant inherited disease characterized by the development of multiple skin appendage tumors such as cylindroma, trichoepithelioma, and spiradenoma (Bignell et al., 2000; Lee et al., 2005) . The physiological functions of CYLD in animal development and tumorigenesis remain largely unclear. Recent studies have indicated that CYLD encodes a deubiquitinating enzyme that, by removing K46-or K63-linked polyubiquitin chains (or both) from its target, modulates multiple signaling pathways in immune and epithelial cells. In vitro studies have suggested that CYLD negatively regulates the p65/p50 NF-kB pathway by removing K63-linked polyubiquitin chains from TRAF2/6 (Brummelkamp et al., 2003; Kovalenko et al., 2003; Massoumi et al., 2006; Trompouki et al., 2003) . Hence, it was proposed that loss of CYLD would result in hyperactivation of p65/p50 NF-kB and survival of tumor cells. However, in contrast to this hypothesis, ectopic activation of this signaling in mouse epithelial tissue results in epidermal hypoplasia and growth inhibition rather than epidermal hyperplasia (Seitz et al., 1998) . Another study has suggested that CYLD deubiquitinates K63-linked polyubiquitination from Bcl-3 and inhibits p50/Bcl-3-or p52/Bcl-3-depedent proliferation in mouse keratinocytes (Massoumi et al., 2006) . Recently, it has been shown that CYLD deubiquitinates both K48and K63-linked polyubiquitin chains from Lck and regulates TCR signaling in thymocytes (Reiley et al., 2006) . Thus, depending on the specific cellular context, CYLD may execute its functions via two different molecular mechanisms: the K48-linked, polyubiquitination-mediated, proteasome-dependent protein degradation and K63-linked, polyubiquitination-mediated endocytosis and signal transduction.
The c-Jun N-terminal kinase (JNK) signaling pathway has been conserved from flies to humans and plays a wide range of roles from stress response to apoptosis (Davis, 2000) . Interestingly, mice deficient for jnk1 show enhanced skin tumor development (She et al., 2002) , a phenotype similar to cyld mutants (Massoumi et al., 2006) . However, the role of CYLD in JNK signaling has remained controversial, and the mechanism unknown (Reiley et al., 2004 (Reiley et al., , 2006 Zhang et al., 2006) . In Drosophila, the Tumor Necrosis Factor (TNF) orthlog Eiger (Egr) triggers the cell death pathway through its receptor Wengen (Wgn), which in turn activates the conserved JNK cascade, the JNKK kinase dTAK1, the JNK kinase Hep, and Drosophila JNK Bsk Moreno et al., 2002) .
Drosophila has been used as a powerful model organism for the genetic dissection of conserved signaling pathways in development. Given that CYLD is conserved from invertebrates to mammals (Bignell et al., 2000) , we characterized the in vivo functions of CYLD in Drosophila by generating dCYLD mutants and transgenic animals expressing wild-type or mutant dCYLD proteins. Our genetic and biochemical analyses indicated that a major function of dCYLD is regulating JNK-mediated cell death through deubiquitinating dTRAF2.
RESULTS AND DISCUSSION

Loss of dCYLD Compromises JNK-Dependent Oxidative Stress Resistance and Lifespan
The Drosophila genome encodes a single CYLD ortholog, dCYLD (CG5603) (Adams et al., 2000) . To obtain the dCYLD mutant, we generated a 5 kb genomic deletion by male recombination (Chen et al., 1998) . This deficiency, termed dCYLD mr4 , deletes the entire upstream region and the first 57 amino acids of dCYLD, as well as the coding regions of two adjacent genes, CG5395 and CG13138 ( Figure 1A) , and thus represents null mutations for these three genes. To obtain flies only mutant for dCYLD, a transgene, pLX107, containing the genomic region for CG5395 and CG13138, was introduced into the fly genome and was able to rescue the lethality of homozygous dCYLD mr4 flies ( Figure 1A ). The rescued flies, which represent null mutants only for dCYLD, were viable and fertile, with no obvious morphological abnormalities (data not shown), suggesting that dCYLD is dispensable for viability and fertility. RT-PCR experiments confirmed that no dCYLD transcripts were produced in homozygous dCYLD mr4 pLX107 flies, as compared with wild-type ( Figure S1 in the Supplemental Data available with this article online). However, we found that dCYLD mr4 pLX107 mutant animals were shorter lived than wild-type or heterozygous dCYLD flies ( Figure 1B ). This phenotype could be rescued by adding one copy of dCYLDRes ( Figure 1B ), a genomic rescue transgene for dCYLD (Figure 1A) , which confirms that loss of dCYLD is the cause of this defect. Similarly, other defects associated with dCYLD mr4 pLX107 are also rescued by the dCYLDRes transgene (Experimental Procedures). Thus, we refer to dCYLD mr4 pLX107 as dCYLD mutants from hereon out.
Shortened animal lifespan may result from compromised oxidative stress tolerance (Beckman and Ames, 1998) . To examine the oxidative stress resistance, 3-day-old flies were challenged with paraquat for a prolonged period of time and their survival rates were measured (Wang et al., 2003) . We found that dCYLD mutants exhibited a significant reduction in survival rate as compared with wild-type or heterozygous dCYLD flies after 24 hr ( Figure 1C ) or 36 hr ( Figure S2 ) of exposure to paraquat, suggesting dCYLD plays a pivotal role in regulating oxidative stress resistance.
JNK signaling has been reported to play an important role in regulating oxidative stress resistance and lifespan in Drosophila (Wang et al., 2003) . We found that ubiquitous expression of Bsk, the Drosophila JNK ortholog, under the control of tubulin promoter, rescues both lifespan and oxidative stress resistance defects in dCYLD mutants ( Figures 1D and 1E ), suggesting that dCYLD regulates these two physiological effects through the JNK signaling pathway.
We have extended our study to other stress conditions and found that dCYLD mutants are less resistant to dry starvation (no food and water, Figure S3 ), a phenotype that has been associated with reduced JNK activity (Wang et al., 2003) . On the other hand, dCYLD mutants do not affect animal survival at high and low temperature conditions (37 C and 4 C, data not shown).
Loss of dCYLD Suppresses Ectopic Egr-Induced JNK Activation and Cell Death
To further examine the role of dCYLD in regulating JNK signaling in animal development, we tested the genetic interactions between dCYLD and Eiger (Egr), the Drosophila ortholog of TNF that triggers the JNK pathway Moreno et al., 2002) . Ectopic expression of Egr, under the control of the GMR promoter (GMR > Egr) and using the Gal4/UAS binary system (Brand and Perrimon, 1993) , induces JNK activation and cell death in the developing eye that results in vastly reduced adult eye size Moreno et al., 2002) ( Figure S4B ; Figure 2C ). The Egr-induced JNK activation and small-eye phenotype was suppressed modestly by deleting one copy of dCYLD ( Figure 2D and data not shown) and suppressed soundly by removing both copies ( Figure S4C ; Figure 2E ). The strong suppression of the Egr eye phenotype in homozygous dCYLD mutants was partially reverted by adding one copy of dCYLDRes ( Figure 2F ). These results indicate that dCYLD is required for Egr-triggered JNK activation and cell death.
The Ubiquitin Carboxyl-Terminal Hydrolase Deubiquitinating Domains Are Necessary for dCYLD Functions dCYLD encodes a protein of 640 amino acids, containing in its N terminal portion a cytoskeleton-associated protein (CAP) domain that is present in proteins associated with microtubules and the cytoskeletal network (Riehemann and Sorg, 1993) , two ubiquitin carboxyl-terminal hydrolases (UCH) domains that are commonly associated with deubiquitinating enzyme activity (D'Andrea and Pellman, 1998), and three CXXC zinc-finger (ZF) motifs with potential protein-protein interaction ability (Giot et al., 2003) ( Figure 2A ). To functionally characterize these motifs, we generated UAS transgenes expressing the wild-type or three mutant versions of dCYLD that delete the CAP domain, the two UCH domains, or the three ZF motifs (Figure 2A ). When expressed under the control of the GMR promoter, neither the full-length nor the dCYLD mutants displayed any detectable phenotype ( Figure 2G and data not shown). When introduced into the GMR > Egr; dCYLD À/À background, wild-type dCYLD released the suppression of the Egr eye phenotype ( Figure 2H ), confirming that the suppressive effect was due to the loss of dCYLD functions. In contrast, dCYLDDUCH had no effect on the suppression of the Egr eye phenotype ( Figure 2J ), and dCYLDDCAP could only partially relieve this suppression ( Figure 2I ), implying that the UCH domains are necessary for dCYLD functions and that the CAP domain is essential for dCYLD to execute its full activity in vivo. Interestingly, expression of dCYLDDZF completely abolished the suppression effect ( Figure 2K ), suggesting that the ZF motifs are dispensable in dCYLD regulation of Egr-induced cell death. (B) Loss of dCYLD reduces lifespan. dCYLD mutant males (W 1118 ; dCYLD mr4 pLX107) show significant reduction of median and maximal lifespan as compared with wild-type (W 1118 ) or heterozygous dCYLD (W 1118 ; dCYLD mr4 pLX107/+) males. This reduction was largely rescued by one copy of dCYLDRes (W 1118 ; dCYLD mr4 pLX107; dCYLDRes/+). Similar results were obtained with females (data not shown). Survival of three independent cohorts with about 100 flies each was monitored over time. Statistical analysis was performed using the log rank test. Cohort sizes and p values are as follows: WT, n = 322; dCYLD/+, n = 288; dCYLD, n = 424; dCYLD; dCYLDRes/+, n = 276; p < 0.001. (C) Loss of dCYLD compromises oxidative stress resistance. Three-day-old flies were fed with 15 mM paraquat in 5% sucrose for twenty-four hours, and their survival rates were measured. dCYLD mutants show significant reduction in survival rates as compared with wild-type or heterozygous dCYLD flies. This reduction was strongly rescued by one copy of dCYLDRes. Data are represented as mean ± SD. (D) The reduced lifespan of dCYLD mutant males (W 1118 ; dCYLD mr4 pLX107) was fully rescued by ubiquitous expression of either Bsk (W 1118 ; dCYLD mr4 pLX107; tub-Gal4/UAS-Bsk) or full-length dCYLD (W 1118 ; dCYLD mr4 pLX107; tub-Gal4/UAS-dCYLD), but not that of dCYLDDUCH Developmental Cell dCYLD Regulates JNK Signaling Ubiquitous expression of the full-length dCYLD, but not dCYLDDUCH, rescues both shortened lifespan and hypersensitivity to paraquat in dCYLD mutants ( Figures 1D  and 1E ), which suggests that the deubiquitinating activity is indispensable for dCYLD to regulate JNK-dependent oxidative stress resistance and lifespan.
dTRAF2 Is Required for Ectopic Egr-Induced Cell Death TNF receptor-associated factors (TRAFs) are important adaptor proteins that bind to TNF receptors and relay TNF signals to the JNK and NF-kB pathways in mammals (Bradley and Pober, 2001) . In Drosophila, Egr signal is (W 1118 ; dCYLD mr4 pLX107; tub-Gal4/UAS-dCYLDDUCH). Similar results were obtained with females (data not shown). Cohort sizes and p values are as follows: dCYLD, n = 424; dCYLD; tub > Bsk, n = 268; dCYLD; tub > dCYLD, n = 247; dCYLD; tub > dCYLDDUCH, n = 230; p < 0.001. (E) The compromised oxidative stress resistance of dCYLD mutants was fully rescued by ubiquitous expression of either Bsk or full-length dCYLD, but not that of dCYLDDUCH. Data are represented as mean ± SD. This phenotype is suppressed partially by deleting one copy (D, UAS-Egr/dCYLD mr4 pLX107; GMR-Gal4/+) and almost fully by removing both copies (E, UAS-Egr dCYLD mr4 /dCYLD mr4 pLX107; GMR-Gal4/+) of endogenous dCYLD gene. The suppression of GMR > Egr phenotype in dCYLD homozygous mutants is partially released by adding one copy of dCYLDRes (F, UAS-Egr dCYLD mr4 / dCYLD mr4 pLX107; GMR-Gal4/dCYLDRes) or expressing dCYLDDCAP (I, UAS-Egr dCYLD mr4 /dCYLD mr4 pLX107; GMR-Gal4/UAS-dCYLDDCAP), and is released fully by the expression of dCYLD (H, UAS-Egr dCYLD mr4 /dCYLD mr4 pLX107; GMR-Gal4/UAS-dCYLD) or dCYLDDZF (K, UAS-Egr dCYLD mr4 /dCYLD mr4 pLX107; GMR-Gal4/UAS-dCYLDDZF), but not that of dCYLDDUCH (J, UAS-Egr dCYLD mr4 /dCYLD mr4 pLX107; GMR-Gal4/ UAS-dCYLDDUCH). Expression of wild-type dCYLD protein in the eye produces no discernible phenotype (G, RNAi (C, UAS-Egr/UAS-dTRAF1-IR; GMR-Gal4/+), but is suppressed strongly by removing one wild-type copy of dTRAF2 gene (D, dTRAF2 EX /+; UAS-Egr/+; GMR-Gal4/+) and suppressed completely by removing both wild-type copies (E, dTRAF2 EX ; UAS-Egr/+; GMR-Gal4/+); it is almost suppressed completely by expressing a dTRAF2 RNAi (F, UAS-Egr/UAS-dTRAF2-IR; GMR-Gal4/+). (G-L) dCYLD and dTRAF2 are required for Egr-induced JNK activation. X-Gal staining of a puc-LacZ reporter gene in third-instar larval eye discs is shown. The weak endogenous puc expression is detected after extensive staining (G, GMR-Gal4/puc E69 ). The puc expression posterior to the MF is significantly reduced in homozygous dCYLD mutants (H, dCYLD mr4 pLX107; GMR-Gal4/ puc E69 ), or is reduced by expressing a dTRAF2 RNAi (I, UAS-dTRAF2-IR/+; GMR-Gal4/ puc E69 ), while the puc expression in disc edge is not affected (arrows in G-I). GMR > Egr induces puc expression posterior to the MF (J, UAS-Egr/+; GMR-Gal4/puc E69 ), which is strongly suppressed by the removal of both wild-type copies of dCYLD (K, UAS-Egr dCYLD mr4 /dCYLD mr4 pLX107; GMR-Gal4/ puc E69 ), or by the expression of a dTRAF2 RNAi (L, UAS-Egr/UAS-dTRAF2-IR; GMR-Gal4/ puc E69 ). Eye discs were dissected from third-instar larvae and stained for b-galactosidase activity as described (Xue and Noll, 2002) . Staining was performed at 37 C for 12 hr (G-I) or at room temperature for 2 hr (J-L). (M-X) Genetic epistatic analysis of dCYLD and dTRAF2 in the Egr-JNK pathway. (M-R) Light micrographs of Drosophila adult eyes are shown. Expression of dTAK1 in developing eyes under the control of the sev promoter induces apoptosis and generates rough eyes with a slightly reduced size (M, sev-Gal4 UAS-dTAK1/+). This phenotype is not suppressed by removing both wild-type copies of dCYLD (N, dCYLD mr4 pLX107; sev-Gal4 UAS-dTAK1/+) or dTRAF2 (O, dTRAF2 EX ; sev-Gal4 UAS-dTAK1/+), nor by expressing a dTRAF2 RNAi (P, sev-Gal4 UAS-dTAK1/UAS -dTRAF2-IR), mediated exclusively by the JNK pathway Moreno et al., 2002) . However, the role of Drosophila TRAF proteins in Egr-JNK signaling remains unclear. The Drosophila genome encodes two TRAFs: dTRAF1, the TRAF2 ortholog; and dTRAF2, the TRAF6 ortholog (Adams et al., 2000) . To determine the role of dTRAF1 and dTRAF2 in Egr-JNK signaling, we checked the effects of loss-offunction mutations and RNAi-mediated downregulation of dTRAF1 or dTRAF2 on the Egr eye phenotype (Cha et al., 2003; Kuranaga et al., 2002) . We found that the Egr-induced small-eye phenotype was not suppressed by either deletion of one copy of the dTRAF1 gene ( Figure 3B ) or coexpression of a dTRAF1 RNAi ( Figure 3C) . In contrast, the Egr eye phenotype was suppressed strongly by removing half of the dosage of dTRAF2 ( Figure 3D ) and suppressed completely by deleting the dTRAF2 gene ( Figure 3E ). Consistently, coexpression of a dTRAF2 RNAi significantly suppressed the Egr eye phenotype ( Figure 3F ). In agreement with our genetic data, dTRAF2 exhibited a much stronger physical interaction with Wgn and dTAK1 than dTRAF1 did (Geuking et al., 2005; Kauppila et al., 2003) . Together, the above results point to dTRAF2, but not dTRAF1, as the adaptor protein that mediates Egr signaling in Drosophila.
dCYLD and dTRAF2 Are Required for Endogenous JNK Signaling To investigate the physiological functions of dCYLD and dTRAF2 in JNK activation, we checked the expression pattern of puckered (puc) in dCYLD or dTRAF2 mutants. puc encodes a JNK phosphatase whose expression is positively regulated by the JNK pathway (Martin-Blanco et al., 1998) , and thus, the puc-LacZ expression of the puc E69 enhancer-trap allele can be used as a readout of JNK activity in vivo (Agnes et al., 1999) . puc is weakly expressed in wild-type third-instar eye discs, and can be detected by prolonged staining (Agnes et al., 1999; Igaki et al., 2002) (Figure 3G ). It has been previously shown that puc expression posterior to the morphogenetic furrow (MF) depends on endogenous Egr signaling . We found that such expression patterns were reduced dramatically in dCYLD mutants ( Figure 3H ) and dTRAF2 RNAi animals ( Figure 3I ). In contrast, puc expression in the disc margin, which is independent of Egr signaling , was not affected (arrows in Figure 3G -3I). GMR > Egr strongly activated puc transcription posterior to the MF (Figure 3J ). This ectopic Egr-induced puc expression was largely blocked by loss of dCYLD ( Figure 3K ) or by expression of dTRAF2 RNAi ( Figure 3L ). Taken together, our observations indicate that both dCYLD and dTRAF2 are physiologically required by the endogenous JNK pathway.
The role of CYLD in modulating JNK signaling in mammalian cells has remained controversial. Consistent with our observation, it was reported that JNK activity diminished in Cyld À/À thymocytes (Reiley et al., 2006) , which implies that CYLD is physiologically required for JNK activation. However, CYLD was also reported to negatively regulate JNK signaling in culture cells (Reiley et al., 2004) and macrophages . Thus, CYLD could positively or negatively regulate JNK signaling in a cell-type-specific manner.
dCYLD Regulates JNK Signaling Through dTRAF2
To genetically map the epistasis of dCYLD and dTRAF2 in the Egr-JNK pathway, we examined the genetic interaction between dTAK1 (JNKKK) and dCYLD or dTRAF2 in the developing eyes. Expression of dTAK1 under the control of the GMR promoter resulted in pupa lethality (data not shown), while dTAK1 expression under the control of the sevenless (sev) promoter (sev > dTAK1) induced extensive cell death in larval eye discs and gave rise to rough eyes with a reduced size (Mihaly et al., 2001; Takatsu et al., 2000) ( Figure 3M ). Loss of dCYLD ( Figure 3N ) or dTRAF2 ( Figure 3O ), or coexpression of a dTRAF2 RNAi ( Figure 3P) , had no effect on the sev > dTAK1 phenotype, while removal of one copy of hep (JNKK) ( Figure 3Q) or bsk (JNK) ( Figure 3R ) partially suppressed the sev > dTAK1 phenotype (Mihaly et al., 2001; Takatsu et al., 2000) , which suggests that dCYLD and dTRAF2 operate upstream of dTAK1 in the Egr-JNK pathway.
Ectopic Egr expression in the dorsal thorax driven by the potent pannier-GAL4 driver resulted in pupa lethality (data not shown). However, when reared at 18 C, these animals survived to adulthood, presumably due to lessened Egr expression caused by reduced Gal4 activity, and produced a small-scutellum phenotype (Figure 3T ). This phenotype could be suppressed by RNAi inactivation of JNK signaling components, e.g., wgn, dTRAF2, dTAK1, hep, or bsk (data not shown), which suggests that the phenotype is caused by activation of JNK signaling. Ectopic expression of dCYLD driven by pannier-GAL4 produced a similar but weaker phenotype (Figure 3U ), which could be fully suppressed by the coexpression of an RNAi of dTRAF2 ( Figure 3W ) and dTAK1 ( Figure 3X ), but not that of wgn ( Figure 3V) . These results indicate that dCYLD functions downstream of Wgn, but upstream of dTRAF2 and dTAK1, in modulating JNK signaling.
RNAi-mediated downregulation of dTRAF2, but not dTRAF1, resulted in compromised oxidative stress resistance and shortened lifespan ( Figure S5 ), which suggests that the role of dTRAF2 in dCYLD-JNK signaling has been conserved in different physiological contexts.
Previous studies have reported that the Shark tyrosine kinase and Src42A regulate JNK signaling in epidermal but is suppressed partially by deleting one copy of hep (Q, hep 1 /+; sev-Gal4 UAS-dTAK1/+) or bsk (R, bsk 1 +/; sev-Gal4 UAS-dTAK1/). (S-X) Light micrographs of Drosophila adult thorax are shown. Compared with wild-type (S, pnr-Gal4/+), expression of Egr (T, UAS-Egr/+; pnr-Gal4/+) or dCYLD (U, UAS-dCYLD; pnr-Gal4/+) under the control of the pnr promoter produces a small-scutellum phenotype (arrow in T). The pnr > dCYLD phenotype is fully suppressed by an RNAi of dTRAF2 (W, UAS-dCYLD; pnr-Gal4/UAS-dTRAF2-IR) or dTAK1 (X, UAS-dCYLD; pnr-Gal4/UAS-dTAK1-IR), but not by one of wgn (V, UAS-dCYLD; pnr-Gal4/UAS-wgn-IR). (Fernandez et al., 2000; Tateno et al., 2000) . However, null mutants for egr and dCYLD are fully viable and do not display the epidermal closure defect Moreno et al., 2002) (data not shown), implying that Shark and Src42A act in parallel to Egr and dCYLD in modulating JNK signaling. Consistent with this interpretation, loss of shark or src42A failed to suppress the GMR > Egr or pnr > dCYLD phenotype (data not shown). In addition, we found that loss of the transcription factor dFOXO could suppress both GMR > Egr and pnr > dCYLD phenotypes (data not shown), which suggests that dFOXO acts downstream of dCYLD in JNK signaling. Consistent with this observation, dFOXO is required downstream of JNK in modulating cell death, oxidative stress resistance, and lifespan (Luo et al., 2007; Wang et al., 2005) .
dCYLD Deubiquitinates and Stabilizes dTRAF2
Overexpression of CYLD in mammalian tissue culture cells negatively regulates NF-kB signaling by deubiquitinating TRAF2/6 (Brummelkamp et al., 2003; Kovalenko et al., 2003; Trompouki et al., 2003) . dCYLD, like its mammalian counterpart, contains two UCH deubiquitinating domains (Bignell et al., 2000) (Figure 2A ). Indeed, as described above, our genetic analysis revealed that the UCH deubiquitinating domains are crucial for the in vivo functions of dCYLD ( Figures 1D and 1E , and Figure 2J ). Furthermore, our genetic epistasis data show that dCYLD acts upstream of dTRAF2 in the JNK pathway. Thus, we hypothesized that dCYLD might act in the JNK pathway to deubiquitinate and subsequently stabilize dTRAF2 by preventing its ubiquitination-mediated proteolytic degradation. To examine this hypothesis in vivo, a FLAG-tagged dTRAF2 transgene (GMR > FLAG-dTRAF2) was introduced into dCYLD mutants and transgenic flies. Proteins were extracted from the heads of these flies for biochemical analyses. We found that loss of dCYLD resulted in a significant reduction in dTRAF2 protein level, while the ubiquitination of dTRAF2 was markedly enhanced ( Figure 4A and Figure S6, lanes 2 and 3) . Both changes were suppressed by dCYLDRes ( Figure 4A and Figure S6 , lane 4). Consistently, overexpression of dCYLD, but not dCYLDDUCH, increased dTRAF2 protein level and decreased its ubiquitination ( Figure 4A and Figure S6 , lanes 5 and 6). These results show that dCYLD functions as a deubiquitinating enzyme that deubiquitinates dTRAF2 and promotes dTRAF2 accumulation in vivo.
Polyubiquitination chains are usually formed on two lysine residues, K48 and K63. It is generally believed that the K48-linked polyubiquitination mediates proteasomedependent protein degradation (Chau et al., 1989) , while the K63-linked polyubiquitination mediates endocytosis and signal transduction (Mukhopadhyay and Riezman, 2007) . Previous work in mammalian culture cells has implicated that CYLD encodes a deubiquitinating enzyme that preferentially cleaves K63-linked polyubiquitin chain from its target proteins for NF-kB signaling (Brummelkamp et al., 2003; Kovalenko et al., 2003; Trompouki et al., 2003) . However, a recent in vivo study in Cyld À/À mice has reported that CYLD could regulate the stability of its target protein by effectively removing K48-linked polyubiquitin chain in thymocytes (Reiley et al., 2006) . Interestingly, JNK activity also diminished in Cyld À/À thymocytes (Reiley et al., 2006) . Thus, the role of CYLD in regulating protein stability and positively modulating JNK signaling could be conserved in mammals.
Conclusions
CYLD mutations in human patients cause dramatic skin tumors. However, the physiological function of CYLD Figure S4. (B) A model for the roles of dCYLD and dTRAF2 in the Egr-JNK signaling pathway (see text). and the mechanism underlying CYLD deficiency-induced tumorigenesis remain largely unknown. By generating the null dCYLD mutation and dCYLD transgenic animals and performing genetic analysis, we show that dCYLD is a critical regulatory component of the JNK signaling pathway. Our genetic epistasis and biochemical analysis further reveal that dCYLD modulates JNK signaling by deubiquitinating dTRAF2 and thus preventing dTRAF2 from ubiquitination-mediated proteolytic degradation. Loss of dCYLD results in augmented ubiquitination and degradation of dTRAF2, which renders cells resistant to apoptosis triggered by JNK signaling. Deregulation of apoptosis has been implicated as a major cause of tumorigenesis (Thompson, 1995) . Consistently, mice deficient for both jnk1 and jnk2 were resistant to apoptosis induced by UV irradiation, anisomycin, and MMS (Tournier et al., 2000) , and jnk1 À/À mice exhibited enhanced skin tumor development (She et al., 2002) , a phenotype that is pathogenically similar to cylindromatosis in CYLD human patients. Together these data argue that modulation of JNK signaling could be a conserved mechanism underlying familial cylindromatosis in CYLD patients.
EXPERIMENTAL PROCEDURES
Plasmid Construction pLX107 and dCYLDRes were produced by cloning the 6.2 kb BglII fragment and 5.9 kb KpnI fragment from cosmid clone 41-F12 into the BamHI and KpnI sites of pW8 vector, respectively. UAS-dCYLD was generated by inserting the 2.1 kb XhoI-EcoRV fragment from the EST clone SD04636 into the pUAST vector. dCYLDDCAP, dCYLDDUCH, and dCYLDDZF were amplified by PCR, sequenced, and inserted into pUAST vector.
Drosophila Strains
Drosophila strains used include: GMR-Gal4, UAS-Egr , l(2)08774 (Spradling et al., 1999) , DTRAF1 ex and DTRAF2 ex (Cha et al., 2003) , puc E69 (Fanto et al., 2000) , hep 1 (Glise et al., 1995) , bsk 1 (Riesgo-Escovar et al., 1996) , sev-Gla4, UAS-dTAK1 (Mihaly et al., 2001) , UAS-Wgn-IR , UAS-dTAK1-IR (Leulier et al., 2002) , UAS-Hep-IR (Ishimaru et al., 2004) , UAS-dTRAF1-IR, and UAS-dTRAF2-IR (Igaki et al., 2006) . pLX107, dCYLDRes, UAS-dCYLD, UAS-dCYLDDCAP, UAS-dCYLDDUCH, UAS-dCYLDDZF, and UAS-Flag-dTRAF2 transgenic flies were generated by standard P element-mediated transformation. More than five independent lines were produced and examined for each transgene and gene expression was verified by RT-PCR. dCYLD mr4 mutants were generated by male recombination (Chen et al., 1998) using the P element l(2)08774 (Spradling et al., 1999) . Genomic DNA from a total of 13 recombinants was PCR amplified and sequenced to determine the molecular lesions. Primers used for PCR were OLX4 (5 0 -GTAGCAGGTCGGAACAGATTC-3 0 ) and PLAC1 (5 0 -CACCCAAGGCTCTGCTCCCACAAT-3 0 ). dCYLD mr4 mutants produced a 0.5 kb PCR product instead of the 5.5 kb fragment generated from the original stock.
Lifespan, Oxidative Stress Resistance, and Dry Starvation Assay Lifespan, oxidative stress resistance, and dry starvation were monitored at 25 C as described (Wang et al., 2003) .
Western Blot
Heads were cut from newly eclosed flies (0-12 hr) and homogenized in lysis buffer . Western blots were performed as described . In brief, lysates were separated on 10% SDS-PAGE gels and transferred to nitrocellulose membranes. After blocking with 5% milk, the membranes were incubated with monoclonal antibodies against FLAG (Sigma) or tubulin (Chemicon), and then done so with a secondary HRP-conjugated anti-mouse IgG (Jackson). Signals were detected with ECL-plus kit (PerkinElmer).
Immunoprecipitation Assay
Fly head lysates were incubated with anti-Flag M2 affinity gel (Sigma) on ice for 1 hr. The immunoprecipitates were washed five times with lysis buffer, separated by 10% SDS-PAGE gels, transferred to nitrocellulose membranes, immunoblotted with antibody against ubiquitin (Invitrogen), and detected as described above.
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